Methyl 3-iodoimidazo[1,2-a]pyridine-7-carboxylate, 95.0%, 1g

4-(4-Bromophenyl)oxan-4-amine, 98%, 250mg

(3-Fluoro-4'-propyl-[1,1'-biphenyl]-4-yl)boronic acid, 95.0%, 25g

7-chloro-4-methoxy-N-(2-morpholinoethyl)benzo[d]thiazol-2-amine, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-5-((tert-butoxycarbonyl)amino)pentanoic acid, 97%, 250mg

Termómetro para agitación, -10 a +60 °C, 200 mm

(2R,4R)-2-METHYLPIPERIDIN-4-OL HCL, 95.0%, 500mg

(R)-2-(Piperidin-3-yl)isoindoline-1,3-dione (2S,3S)-2,3-dihydroxysuccinate, 95.0%, 5g

3,5-Dimethyl-1,2,4-triazole>95.0%(GC)(T)5g

(R)-1-Phenylethyl (5-(4-bromophenyl)-3-methylisoxazol-4-yl)carbamate, 97.0%, 250mg

tert-butyl 4-(4-((6-(2,4-dichlorophenyl)-8-ethyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)-2-fluorophenyl)piperazine-1-carboxylate, 98%, 500mg

2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95+%, 5g

N-Methyl-2-nitroaniline, 95.0%, 25g